Related Experiment Video
Updated: Dec 26, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
A curable pseudo-dementia related to an atypical presentation of giant cell arteritis
Clément Lahaye1, Manuel Sanchez2, Audrey Rouet3
1Unité mobile de Gériatrie, CHU Clermont-Ferrand, 63000 Clermont-Ferrand, France.
Insights
Giant cell arteritis (GCA) can cause rapid cognitive decline and ataxia. Prompt diagnosis and treatment with corticosteroids and immunosuppressants led to symptom improvement in this rare case.
Area of Science:
- Neurology
- Rheumatology
- Vascular Medicine
Background:
- Giant cell arteritis (GCA) is a systemic vasculitis typically affecting large and medium arteries.
- Cranial GCA commonly presents with headache and visual disturbances, but neurological manifestations can be diverse.
- Atypical presentations, including significant cognitive decline, are less common but recognized complications.
Observation:
- A 70-year-old patient presented with rapid cognitive decline, functional impairment, weight loss, and cerebellar ataxia.
- 18FDG-PET imaging revealed metabolically active vasculitis in the brachiocephalic trunk.
- Temporal artery biopsy confirmed pan-arteritis, leading to a diagnosis of GCA with vascular involvement.
Findings:
- The patient experienced progressive cognitive improvement following treatment with corticosteroids and immunosuppressive therapy.
- This case highlights the potential for GCA to manifest with severe neurological symptoms, including cognitive impairment and ataxia.
- Published reports suggest a range of cognitive symptoms, such as memory impairment and delirium, may be linked to GCA.
Implications:
- GCA should be considered in the differential diagnosis of unexplained cognitive impairment, especially when accompanied by systemic inflammation and weight loss.
- Early recognition and treatment of GCA can lead to reversible neurological deficits and improved patient outcomes.
- This case underscores the importance of advanced imaging (18FDG-PET) and biopsy in diagnosing GCA with atypical vascular and neurological involvement.
Abstract:
A 70-year-old patient was admitted with rapidly progressive cognitive decline associated with limitations in activities of daily living, weight loss and cerebellar ataxia. The diagnosis of giant cell arteritis (GCA) with vascular involvement was made, based on the presence of a metabolically active vasculitis of the brachiocephalic trunk on 18FDG-PET imaging. Temporal artery biopsy also revealed pan-arteritis. A progressive regression of cognitive disorders occurred under corticosteroid treatment and immunosuppressive therapy. Previously published case reports concerning this atypical presentation of GCA are scarce. They suggest that numerous cognitive symptoms, such as impairment of short-term memory, disorientation, delirium, impaired attention or visual hallucinations might be related to GCA. Thus, this diagnosis should be considered as a curable cause of unexplained cognitive impairment associated with weight loss and systemic inflammation.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Alzheimer's Disease: Treatment
Rheumatic Heart Disease I: Introduction
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

